Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,474Revenue (TTM) $M3,542Net Margin (%)9.2Altman Z-Score4.0
Enterprise Value $M17,317EPS (TTM) $4.3Operating Margin %10.5Piotroski F-Score6
P/E(ttm)52.5Beneish M-Score-2.7Pre-tax Margin (%)12.9Higher ROA y-yN
Price/Book10.110-y EBITDA Growth Rate %8.5Quick Ratio1.9Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %0.7Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow46.4y-y EBITDA Growth Rate %-13.2ROA % (ttm)6.4Higher Current Ratio y-yY
Dividend Yield %0.4PEG76.9ROE % (ttm)21.0Less Shares Outstanding y-yN
Payout Ratio %22.0Shares Outstanding M73.5ROIC % (ttm)21.5Gross Margin Increase y-yY

Gurus Latest Trades with BCR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRDonald Yacktman 2016-06-30 Reduce-0.74%$202.67 - $235.16
($216.98)
$ 223.503%Reduce -36.85%806,300
BCRYacktman Fund 2016-06-30 Reduce-0.7%$202.67 - $235.16
($216.98)
$ 223.503%Reduce -27.78%650,000
BCRYacktman Focused Fund 2016-06-30 Sold Out -0.65%$202.67 - $235.16
($216.98)
$ 223.503%Sold Out0
BCRJoel Greenblatt 2016-06-30 Reduce-0.33%$202.67 - $235.16
($216.98)
$ 223.503%Reduce -96.30%5,582
BCRJoel Greenblatt 2016-03-31 Add0.32%$176.1 - $202.88
($188.46)
$ 223.5019%Add 1864.03%150,877
BCRVanguard Health Care Fund 2016-03-31 Sold Out -0.09%$176.1 - $202.88
($188.46)
$ 223.5019%Sold Out0
BCRDonald Yacktman 2016-03-31 Reduce-0.01%$176.1 - $202.88
($188.46)
$ 223.5019%Reduce -0.53%1,276,894
BCRVanguard Health Care Fund 2015-12-31 Reduce-0.23%$179.33 - $195.76
($187.31)
$ 223.5019%Reduce -71.10%226,841
BCRDonald Yacktman 2015-12-31 Reduce-0.22%$179.33 - $195.76
($187.31)
$ 223.5019%Reduce -12.33%1,283,759
BCRYacktman Focused Fund 2015-12-31 Reduce-0.21%$179.33 - $195.76
($187.27)
$ 223.5019%Reduce -30.00%140,000
BCRYacktman Fund 2015-12-31 Reduce-0.12%$179.33 - $195.76
($187.27)
$ 223.5019%Reduce -5.26%900,000
BCRTom Gayner 2015-12-31 Add0.03%$179.33 - $195.76
($187.31)
$ 223.5019%Add 125.00%9,000
BCRJoel Greenblatt 2015-12-31 Add0.01%$179.33 - $195.76
($187.31)
$ 223.5019%Add 94.19%7,682
BCRYacktman Focused Fund 2015-09-30 Reduce-1.86%$171.2 - $200.53
($189.23)
$ 223.5018%Reduce -78.95%200,000
BCRDonald Yacktman 2015-09-30 Reduce-1.19%$171.2 - $200.53
($189.23)
$ 223.5018%Reduce -47.20%1,464,225
BCRYacktman Fund 2015-09-30 Reduce-0.71%$171.2 - $200.53
($189.23)
$ 223.5018%Reduce -29.63%950,000
BCRVanguard Health Care Fund 2015-09-30 Reduce-0.04%$171.2 - $200.53
($189.23)
$ 223.5018%Reduce -14.01%784,800
BCRTom Gayner 2015-09-30 Buy 0.02%$171.2 - $200.53
($189.23)
$ 223.5018%New holding4,000
BCRJoel Greenblatt 2015-09-30 Buy 0.01%$171.2 - $200.53
($189.23)
$ 223.5018%New holding3,956
BCRYacktman Focused Fund 2015-06-30 Reduce-0.54%$165.24 - $176.25
($170.8)
$ 223.5031%Reduce -22.13%950,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
RING TIMOTHY MChairman and CEO 2016-09-28Sell92,293$227.81-1.89view
RING TIMOTHY MChairman and CEO 2016-09-26Sell110,000$228.96-2.38view
Larson Betty DVP - Human Resources 2016-09-19Sell4,032$225.33-0.81view
Khichi Samrat S.Sr. VP, Gen Counsel & Secy. 2016-09-06Sell9,183$221.011.13view
DeFord John ASr. VP Sci Tech and Clin Afrs 2016-09-06Sell7,928$221.061.1view
HOLLAND CHRISTOPHER SSenior Vice President and CFO 2016-05-27Sell3,970$219.891.64view
Groetelaars John PGroup President 2016-05-17Sell1,162$219.881.65view
Thompson Tommy GDirector 2016-05-12Sell500$219.521.81view
WHITE TONY LDirector 2016-05-05Sell1,200$216.193.38view
Beasley Jim CGroup President 2016-04-28Sell4,709$2153.95view

Quarterly/Annual Reports about BCR:

News about BCR:

Articles On GuruFocus.com
The Yacktman Focused Fund Sells Out of C.R. Bard Inc. Jul 19 2016 
5 Stocks Hit 52-Week High Prices Jul 11 2016 
5 Companies Have Hit 52-Week Highs Jun 21 2016 
5 Companies Achieve 52-Week Highs Jun 07 2016 
Dividends’ True Contribution to Total Return May Surprise You Mar 24 2016 
Medical Products Company CR Bard Has Stable Business Mar 09 2016 
The Conundrum in Health Care Investing Mar 06 2016 
Investment Ideas Trading With Very Low P/S Ratio Jan 13 2016 
CR Bard: Dividend Aristocrats Part 25 of 52 Nov 14 2015 
Donald Yacktman Comments on C.R. Bard Nov 05 2015 

More From Other Websites
C.r. Bard Inc (BCR) Chairman and CEO Timothy M Ring Sold $21 million of Shares Sep 29 2016
C.r. Bard Inc (BCR) Chairman and CEO Timothy M Ring Sold $25.2 million of Shares Sep 27 2016
LUTONIX® Global Real-World Registry 24-Month Outcomes Presented at VIVA 2016 Sep 22 2016
C.R. Bard, Inc. (New Jersey) – Value Analysis (NYSE:BCR) : September 20, 2016 Sep 20 2016
CR Bard (BCR) Gets FDA's IDE Approval for Lutonix DCB Sep 20 2016
FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee Drug Coated Balloon Sep 19 2016
C.R. Bard, Inc. (New Jersey) breached its 50 day moving average in a Bullish Manner : BCR-US :... Sep 19 2016
C.R. Bard upgraded by Wells Fargo Sep 16 2016
ETF’s with exposure to C.R. Bard, Inc. (New Jersey) : September 9, 2016 Sep 09 2016
Bard to Present at Morgan Stanley Global Healthcare Conference Sep 06 2016
A Look at How C.R. Bard’s Valuation Compares to Its Peers Sep 01 2016
Analyzing C.R. Bard’s Strong Product Pipeline Aug 31 2016
C.R. Bard Is Expected to Have a Strong Performance in 2016 Aug 31 2016
Analysts’ Recommendations for C.R. Bard in 2016 Aug 31 2016
ETF’s with exposure to C.R. Bard, Inc. (New Jersey) : August 29, 2016 Aug 29 2016
ETF’s with exposure to C.R. Bard, Inc. (New Jersey) : August 18, 2016 Aug 18 2016
ETF’s with exposure to C.R. Bard, Inc. (New Jersey) : August 4, 2016 Aug 04 2016
C.R. Bard, Inc. (New Jersey) :BCR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 Aug 03 2016
BARD C R INC /NJ/ Financials Aug 02 2016
Analysts’ Recommendations for C.R. Bard after Its 2Q Earnings Post Aug 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)